Ten-year all-cause mortality following staged percutaneous revascularization in patients with complex coronary artery disease.

[1]  P. Serruys,et al.  Safety and Efficacy of 1-Month Dual Antiplatelet Therapy (Ticagrelor + Aspirin) Followed by 23-Month Ticagrelor Monotherapy in Patients Undergoing Staged Percutaneous Coronary Intervention (A Sub-Study from GLOBAL LEADERS). , 2020, The American journal of cardiology.

[2]  P. Kolh,et al.  Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial , 2019, The Lancet.

[3]  P. Serruys,et al.  Impact of Staging Percutaneous Coronary Intervention in Left Main Artery Disease: Insights From the EXCEL Trial. , 2017, JACC. Cardiovascular interventions.

[4]  P. Serruys,et al.  Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance Document. , 2018, JACC. Cardiovascular interventions.

[5]  P. Serruys,et al.  Five-year outcomes of staged percutaneous coronary intervention in the SYNTAX study. , 2015, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[6]  E. Brilakis,et al.  Staging of multivessel percutaneous coronary interventions: An expert consensus statement from the Society for Cardiovascular Angiography and Interventions , 2012, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[7]  P. Serruys,et al.  The impact of patient and lesion complexity on clinical and angiographic outcomes after revascularization with zotarolimus- and everolimus-eluting stents: a substudy of the RESOLUTE All Comers Trial (a randomized comparison of a zotarolimus-eluting stent with an everolimus-eluting stent for percutan , 2011, Journal of the American College of Cardiology.

[8]  Percutaneous revascularization for stable coronary artery disease temporal trends and impact of drug-eluting stents. , 2010, JACC. Cardiovascular interventions.